PDCD1 and neoplasm: Furthermore, the combinationof GOx-DOX-LGP with anti-PD-1 checkpoint blockade transformed theimmunosuppressive tumor microenvironment into an immunostimulatoryniche, enhancing CD8+ T-cell infiltration and cytotoxicactivity.